Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - GoodwillEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares OutstandingWages, Salaries and Other
Ratios

Harvard Bioscience (HBIO) Other Gross PP&E Adjustments (2016 - 2025)

Historic Other Gross PP&E Adjustments for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to -$8.4 million.

  • Harvard Bioscience's Other Gross PP&E Adjustments fell 721.68% to -$8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.4 million, marking a year-over-year decrease of 721.68%. This contributed to the annual value of $14.2 million for FY2024, which is 1026.08% up from last year.
  • Per Harvard Bioscience's latest filing, its Other Gross PP&E Adjustments stood at -$8.4 million for Q3 2025, which was down 721.68% from -$8.9 million recorded in Q2 2025.
  • In the past 5 years, Harvard Bioscience's Other Gross PP&E Adjustments ranged from a high of $14.2 million in Q4 2024 and a low of -$11.8 million during Q1 2021
  • Over the past 5 years, Harvard Bioscience's median Other Gross PP&E Adjustments value was -$8.0 million (recorded in 2023), while the average stood at -$4.2 million.
  • In the last 5 years, Harvard Bioscience's Other Gross PP&E Adjustments crashed by 25647.5% in 2021 and then surged by 4445.36% in 2023.
  • Quarter analysis of 5 years shows Harvard Bioscience's Other Gross PP&E Adjustments stood at $10.4 million in 2021, then grew by 12.84% to $11.7 million in 2022, then increased by 10.26% to $12.9 million in 2023, then rose by 10.26% to $14.2 million in 2024, then tumbled by 158.91% to -$8.4 million in 2025.
  • Its Other Gross PP&E Adjustments was -$8.4 million in Q3 2025, compared to -$8.9 million in Q2 2025 and -$10.3 million in Q1 2025.